Treatments · Keratoconus · Intracorneal Ring Segments · Updated May 2026
Private Intacs corneal ring keratoconus surgery, UK 2026
Intacs (Addition Technology) are tiny crescent-shaped PMMA intracorneal ring segments that a consultant corneal surgeon inserts into a precisely placed femtosecond-laser channel in the mid-peripheral cornea. Once in position they mechanically flatten the steepest cone of keratoconus or post-LASIK ectasia, regularise the corneal shape, reduce irregular astigmatism and improve spectacle and contact-lens-corrected vision. Intacs are usually combined with corneal cross-linking (CXL) to halt biomechanical progression. At CQC-registered UK centres in 2026, private self-pay Intacs surgery is typically £3,000-£4,500 per eye standalone and £4,500-£6,000 per eye combined with cross-linking.
- Typical cost: £3,000-£4,500 per eye standalone; £4,500-£6,000 combined with CXL.
- What it does: mechanically flattens the cone and regularises corneal shape.
- Best for: progressive keratoconus or post-LASIK ectasia with contact-lens intolerance.
- Procedure: day-case femtosecond channel and segment insertion under topical anaesthesia, minutes per eye.
- Reversible: segments can be removed or exchanged if needed.
Private consultant corneal assessment: 0800 852 7782. Same-week appointments at CQC-registered UK clinics; transparent UK 2026 self-pay and insurer-billed pathways.
Fast answer: what does Intacs surgery cost and what does it do?
Intacs are tiny PMMA crescent segments inserted into a femtosecond-laser-created channel in the mid-peripheral cornea. They mechanically flatten the steep cone of keratoconus or post-LASIK ectasia, regularise the corneal shape and typically reduce best-corrected spectacle astigmatism by several dioptres, improving glasses tolerance, contact-lens fit and quality of vision. In the UK in 2026, private self-pay Intacs surgery is typically £3,000-£4,500 per eye standalone and £4,500-£6,000 per eye combined with corneal cross-linking (the gold-standard combination for progressive keratoconus).
Typical cost per eye
£3,000-£4,500 standalone; £4,500-£6,000 with CXL.
What it does
Mechanically flattens the cone and regularises corneal shape.
Procedure time
10-15 minutes per eye, topical drops, day-case.
Reversibility
Segments can be removed or exchanged.
Honest one-liner: Intacs reshape your own cornea rather than replacing it — they are the natural step between cross-linking and corneal transplantation in progressive keratoconus, particularly in patients who can no longer tolerate contact lenses but are not yet candidates for a transplant.
What are Intacs corneal ring segments?
Intacs are thin, semi-circular intracorneal ring segments (ICRS) manufactured by Addition Technology (a Johnson & Johnson Vision company) from biocompatible polymethylmethacrylate (PMMA), the same material that has been used safely in intraocular lenses for many decades. Each segment is a few millimetres long and a fraction of a millimetre thick, and is inserted into a precisely engineered channel created by a femtosecond laser at approximately 70 to 80 percent stromal depth in the mid-peripheral cornea, just outside the central visual axis.
The mechanism is mechanical, not optical. Pulling the corneal lamellae outward and flattening the central cornea reduces the steepness of the cone, regularises the corneal asphericity, decreases higher-order aberrations and brings the corneal shape closer to a normal, regular prolate ellipse. The result is typically a meaningful reduction in cylindrical refractive error, a flatter and more regular topographic map, and significantly improved spectacle-corrected and contact-lens-corrected acuity. The segments do not stop keratoconus progression on their own, which is why they are usually combined with corneal cross-linking either at the same operation or as a staged procedure.
In 2026, Intacs in the UK private corneal practice are placed by femtosecond laser (Intralase or equivalent platform), which has replaced the older mechanical pocket-creator technique and has improved precision, predictability and safety. Segments are available in different thicknesses and arc lengths so the surgeon can custom-pair them to the patient's topographic pattern. See our wider treatments hub for the broader corneal menu.
UK 2026 private Intacs cost per eye
For sibling cornea cost pages, see our corneal cross-linking cost page and the DMEK corneal transplant cost page for end-stage comparators.
What is included in a private Intacs package?
Consultant corneal assessment
Best-corrected acuity, manifest refraction, slit-lamp examination, dilated fundus examination, intraocular pressure and ocular surface assessment.
Corneal imaging and biomechanics
Scheimpflug topography (Pentacam or equivalent), corneal pachymetry, anterior segment OCT and corneal biomechanical assessment to confirm keratoconus pattern and rule out subclinical disease in the fellow eye.
Segment selection
Intacs segment thickness and arc length are matched to the patient's topographic pattern and the steep meridian.
Theatre, surgeon and femtosecond laser
CQC-registered ophthalmic day-case theatre, consultant corneal surgeon, theatre team and the femtosecond laser channel-creation platform.
Intacs segments
The PMMA segments themselves, in the precise thickness and arc length selected for your eye.
Follow-up to 6 months
Reviews at day 1, week 1, month 1, month 3 and month 6 with topography, refraction and contact-lens or spectacle refitting as needed.
What does the evidence say about Intacs?
Intacs have been used in keratoconus and post-LASIK ectasia internationally since the early 2000s, and the device received FDA Humanitarian Device Exemption approval for keratoconus in 2004. There is now more than two decades of peer-reviewed evidence in journals including the Journal of Cataract & Refractive Surgery, the American Journal of Ophthalmology and Cornea, supporting consistent benefit on corneal shape and visual outcomes in carefully selected patients with mild to moderate progressive keratoconus or post-LASIK ectasia who are intolerant of spectacles or contact lenses.
Across these studies, mean reductions in maximum keratometry (Kmax) of 2 to 4 dioptres and reductions in manifest cylindrical refractive error of 1 to 3 dioptres are typical. Mean uncorrected and best-corrected visual acuity improve by 2 to 3 Snellen lines in many cohorts, and a substantial proportion of patients who were unable to wear contact lenses pre-Intacs return to comfortable rigid gas-permeable, hybrid or scleral lens wear after surgery. The 2017-2024 generation of femtosecond-laser studies has been particularly favourable on safety, with very low rates of channel deposits, segment migration or infectious keratitis and an excellent long-term tolerance profile.
Intacs do not, on their own, stop the biomechanical progression of keratoconus, and combination with corneal cross-linking is now standard of care in any patient with documented progression. Combined Intacs-plus-CXL pathways are supported by published cohorts demonstrating both topographic improvement and disease stabilisation at 12, 24 and 60 months. See our corneal cross-linking cost page for the CXL component.
Intacs vs other keratoconus treatments
See our pages on CTAK keratoconus corneal tissue addition, DALK transplant for keratoconus, the broader ICL treatments page and EVO ICL for high myopia as a potential later step after Intacs and cross-linking have stabilised the cornea.
Are you a candidate for Intacs?
Good candidates
- Adults with confirmed mild to moderate keratoconus or post-LASIK ectasia.
- Contact-lens intolerant or unable to achieve adequate spectacle-corrected vision.
- Sufficient corneal thickness (typically >400 microns at the channel depth).
- Clear central cornea without dense scarring.
- Realistic expectations: improvement in shape and acuity, not necessarily glasses-free vision.
Better suited to other treatments
- Advanced keratoconus with dense central scarring (consider DALK).
- Very thin corneas where safe channel depth is not achievable.
- Acute corneal hydrops or recent inflammatory episode.
- Active or uncontrolled ocular surface disease.
- Unrealistic expectations after thorough counselling.
Candidacy is decided after a structured corneal consultation that includes Scheimpflug topography, pachymetry and biomechanical assessment. Many patients start with a free initial online review before an in-person workup.
NHS vs private Intacs in the UK
NHS access to Intacs in the UK in 2026 is limited and variable by region. Most NHS corneal services prioritise corneal cross-linking for progressive keratoconus and reserve intracorneal ring segment surgery for selected contact-lens-intolerant patients in tertiary teaching centres, sometimes with waiting times of many months. NHS commissioning of Intacs has been inconsistent for over a decade and many patients with significant disease end up being offered specialist contact lenses or, in advanced cases, a corneal transplant.
The private route offers rapid consultant corneal assessment, modern Scheimpflug topography and biomechanical workup, choice of an experienced ICRS surgeon performing routine cases, combined Intacs-plus-CXL in a single operation where appropriate, and same-week or same-month scheduling. After Intacs and cross-linking have stabilised the cornea, a private pathway also provides smooth follow-on access to specialist contact lens fitting or, where indicated, a stable-eye phakic ICL.
Insurance and funding
Several major UK private medical insurers (Bupa, AXA, Aviva, Vitality) will consider intracorneal ring segment surgery in documented keratoconus or post-LASIK ectasia where there is contact-lens intolerance or reduced best-corrected acuity, subject to pre-authorisation. Cover is usually given on a case-by-case basis with supporting topography and clinical letter. Cross-linking is more consistently covered as a recognised treatment for progressive keratoconus. The clinic can usually liaise directly with your insurer once a consultant has confirmed indication.
For self-pay patients, transparent fixed quotes and finance plans are available; see our finance page and insured patients page.
Risks and limitations of Intacs
- Under- or overcorrection: the topographic and refractive effect may be smaller or larger than planned and may require segment exchange or repositioning.
- Channel deposits: small whitish deposits along the channel margins, usually visually insignificant.
- Segment migration: rare with femtosecond channels; correction is straightforward.
- Segment extrusion: very rare; usually associated with channels too shallow or thin overlying tissue.
- Infectious keratitis: small (around 1 in 2,000-5,000) risk shared with any corneal procedure.
- Glare and halos: some patients describe mild night-vision halos for the first weeks; these usually settle.
- Disease progression: Intacs do not stop biomechanical progression and need to be combined with cross-linking in progressive disease.
Your surgeon will go through these and any individual factors in your case at consent, and you will be given a written, named contact route for urgent post-operative concerns.
Recovery timeline after Intacs
First 24-48 hours
Mild gritty sensation, watering and light sensitivity; vision may be hazy. Antibiotic and steroid drops; protective shield at night.
Week 1
Most patients return to office work and screens; combined Intacs + CXL recovery is slower due to epithelial healing.
Month 1-3
Refraction stabilising; new spectacle prescription or contact lens refit can be planned.
6 months
Final topographic effect and long-term contact-lens fit or spectacle correction confirmed; stable-eye phakic ICL considered for residual refractive error.
How to choose a UK Intacs clinic
- Consultant cornea and refractive fellowship: the surgeon should have completed a cornea and external eye disease fellowship and perform ICRS, CXL and lamellar transplants routinely.
- Documented Intacs case-load: ask how many segments the surgeon implants annually and the topographic outcomes.
- Femtosecond channel platform: femtosecond laser channel-creation rather than older mechanical pocket-creator.
- Modern imaging: in-house Scheimpflug topography (Pentacam or equivalent), pachymetry, anterior segment OCT and corneal biomechanics.
- Full keratoconus menu: the clinic should also offer CXL, CTAK, DALK and specialist contact-lens fitting so the right treatment is offered.
- CQC registration: day-case theatres should be CQC-registered with full sterile and anaesthetic capability.
- Written package: a transparent, fixed quote that includes consultant fees, the segments, the laser, theatre and a defined follow-up package.
For an independent assessment of whether Intacs are right for your keratoconus or post-LASIK ectasia, request a free initial online consultation or make an in-person appointment.
Intacs frequently asked questions
How much does Intacs surgery cost in the UK in 2026?
Private self-pay Intacs surgery in the UK in 2026 is typically £3,000-£4,500 per eye standalone and £4,500-£6,000 per eye combined with corneal cross-linking. Bilateral packages and segment-revision pricing are listed in the pricing table above.
Will Intacs cure my keratoconus?
No single treatment cures keratoconus. Intacs reshape the cornea and typically improve spectacle and contact-lens-corrected vision, but they do not stop biomechanical progression on their own. Combined Intacs-plus-cross-linking is the standard private pathway in progressive disease because it pairs reshaping with stabilisation.
Are Intacs permanent?
Intacs are designed to remain in the cornea indefinitely, but they are also fully reversible: a surgeon can remove or exchange a segment in a brief procedure if the response is suboptimal or the patient no longer needs them.
Does Intacs surgery hurt?
The procedure is performed under topical anaesthetic drops, and most patients feel pressure, light and brief movement rather than pain. There is a mild gritty sensation and watering for one to two days afterwards that settles with lubricants and topical drops.
How long is the recovery after Intacs?
Most patients return to office work and screens within a few days; vision continues to improve over weeks. Combined Intacs + CXL recovery is slower because of epithelial healing after the cross-linking component. Final topographic effect and stable refraction are usually seen by three to six months.
Will I still need glasses or contact lenses after Intacs?
Yes, in most cases. Intacs improve the corneal shape and reduce astigmatism, which typically improves spectacle-corrected vision and makes contact lens fitting much easier; they do not aim to deliver glasses-free vision. Many patients who were previously contact-lens intolerant can resume comfortable RGP or scleral lens wear after Intacs.
Can Intacs be combined with cross-linking in one operation?
Yes. Same-session combined Intacs and corneal cross-linking is now common practice in progressive keratoconus and is the standard private pathway in many UK clinics. The Intacs channel is created and segments inserted, and CXL is applied to stabilise the cornea, in a single sterile sitting.
How is Intacs different from CTAK?
Intacs are synthetic PMMA segments; CTAK uses precisely shaped sterile allogenic corneal tissue arcs to do a similar shape-modification job. CTAK can address larger or more advanced cones that would be undersized for Intacs and may be preferred when biological tissue is felt to be a better match.
When should I have a corneal transplant instead?
A corneal transplant, usually a deep anterior lamellar keratoplasty (DALK), is the right step when the cone is too advanced for reshaping, when there is significant central corneal scarring after hydrops, or when Intacs or CTAK trials have not delivered acceptable vision and contact lens tolerance.
Can I have Intacs in both eyes?
Yes, where both eyes meet criteria. The eyes are usually operated one to four weeks apart so the surgeon can confirm response and refine segment selection in the second eye if needed.
What if Intacs do not give me enough improvement?
If the topographic and refractive effect is smaller than planned, a segment can be exchanged for a thicker one or repositioned. If significant residual myopia or astigmatism remains after Intacs and cross-linking have stabilised the cornea, a phakic ICL or, in older eyes, a refractive lens exchange can be considered.
Will my private medical insurance pay for Intacs?
Several major UK insurers will consider Intacs in documented keratoconus or post-LASIK ectasia with contact-lens intolerance, subject to pre-authorisation and supporting topography. Cross-linking is more consistently covered as a recognised progressive keratoconus treatment. The clinic can liaise directly with your insurer.
Can I have laser eye surgery (LASIK or SMILE) instead?
No. Excimer laser refractive surgery such as LASIK is contraindicated in keratoconus and post-LASIK ectasia, because thinning further would worsen the cone. Vision correction for residual refractive error after Intacs and cross-linking is delivered through a phakic ICL, scleral or RGP contact lenses, or spectacles.
Methodology and sources
UK 2026 self-pay pricing on this page reflects published private fees from CQC-registered ophthalmic providers and consultant corneal services at the time of last review (May 2026), expressed as typical per-eye ranges rather than fixed prices. Clinical content has been written by the Eye Surgery Clinic editorial team, reviewed by a UK GMC-registered consultant ophthalmologist with cornea and external eye disease subspecialty interest. Evidence is drawn from Addition Technology regulatory documents, FDA Humanitarian Device Exemption labelling for Intacs in keratoconus, peer-reviewed cohort and randomised studies in JCRS, AJO and Cornea between 2004 and 2026, ESCRS, AAO and UKISCRS meeting presentations, and Royal College of Ophthalmologists and EuCornea guidance. Page last reviewed 24 May 2026 against the live URL set on eyesurgeryclinic.co.uk.
Book a consultant corneal assessment
Find out whether Intacs and corneal cross-linking are right for your keratoconus or post-LASIK ectasia with a same-week consultant appointment, full Scheimpflug topography workup and a transparent UK 2026 quote.
Or call 0800 852 7782.
Back to Treatments